Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Spectrum Pharmaceuticals logo — Innovative solutions driving advancements in cancer treatmen...

Spectrum Pharmaceuticals

Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.

Founded 1987 51-200 employees Post Ipo Debt Total: $235.98M Biopharma, Biotechnology +1

General Information

Company Name Spectrum Pharmaceuticals
Founded Year 1987
Employees 51-200
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post Ipo Debt
Social

Get notified when Spectrum Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a biopharmaceutical company founded in 1987, with a focus on acquiring, developing, and commercializing innovative and targeted drug products within the field of oncology. The company's slogan emphasizes its commitment to driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products. Spectrum Pharmaceuticals has established an impressive track record in in-licensing and acquiring unique drugs, as well as in clinical development. Its last investment of $30.00M, a Post-IPO Debt investment, was made on 23 September 2022 and was led by SLR Capital Partners. The company operates within the industries of Biopharma, Biotechnology, and Health Care.

Taxonomy: biopharmaceutical company, oncology, therapeutic products, drug development, clinical development, commercialization, targeted drug products, innovation, acquisition, licensing, cancer treatment, strategic development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 23 Sep 2022
Post-IPO Equity •••••• 1 •••• •••• 04 Jan 2022
Post-IPO Equity •••••• - 29 Jul 2020
Post-IPO Equity •••••• - 29 Apr 2016
Grant •••••• - 03 Nov 2010

View All 9 Funding Rounds

Spectrum Pharmaceuticals Alternatives & Competitors

Spectrum Pharmaceuticals vs
Catalent
Catalent United States

Catalent is a leading provider of advanced drug delivery technologies, development, and manufacturin...

12547 employees
Spectrum Pharmaceuticals vs
Delpharm
Delpharm France

A worldwide leader in contract development and manufacturing of medicines

Late Stage
3905 employees
Health Care, Manufacturing
Spectrum Pharmaceuticals vs
Leap Therapeutics
Leap Therapeutics United States

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and develop...

Post Ipo Equity
51 employees
Biotechnology, Life Sciences

FAQ About Spectrum Pharmaceuticals

Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.
Spectrum Pharmaceuticals was founded in 1987.
Spectrum Pharmaceuticals operates in the following industries: Biopharma, Biotechnology, Health Care.
Spectrum Pharmaceuticals has approximately 51-200 employees.
Spectrum Pharmaceuticals has completed 9 funding rounds, raising a total of $235.98M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Spectrum Pharmaceuticals include Catalent, Delpharm, Leap Therapeutics, Tetralogic Pharmaceuticals, CASI Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Spectrum Pharmaceuticals and Catalent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Spectrum Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes